The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Medical professionals are seeing an uptick in requests from clients unhappy with the droopy faces popular diabetes medicines have left behind.

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn't ...

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...

Ozempic and licensed weight loss drugs may come with an overlooked risk, dietitians have warned. Aside from the potential side effects and physical changes that one can expect from starting a new ...

Some patients taking weight-loss drugs, like Ozempic, are beginning to report slower or no weight loss as their bodies build ...

Analysts believe Hims & Hers will earn $0.57 per share this year and $0.80 next year. That prices the stock at 17 times next ...

In our content, we occasionally include affiliate links. Should you click on these links, we may earn a commission, though this incurs no additional cost to you. Your use of this website signifies ...

Ozempic, Wegovy, Mounjaro, Zepbound: Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs their popularity will slow down ...

The US Food and Drug Administration approved Ozempic in 2017 to treat Type 2 diabetes in adults and Wegovy in 2021 for adult weight loss. They are part of a class of drugs that mimic the GLP-1 ...

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat ... runny nose and sore throat. While other gastrointestinal issues are mentioned in the 15-page ...